116 related articles for article (PubMed ID: 19077069)
1. Bone mass density and associated factors in cystic fibrosis patients of young age.
Douros K; Loukou I; Nicolaidou P; Tzonou A; Doudounakis S
J Paediatr Child Health; 2008 Dec; 44(12):681-5. PubMed ID: 19077069
[TBL] [Abstract][Full Text] [Related]
2. [Bone mass in patients with cystic fibrosis of the pancreas. Relationship with anthropometric parameters and genotype].
Yeste D; Liñán S; Cobos N; Gussinyé M; del Río L; Carrascosa A
Med Clin (Barc); 1998 Oct; 111(13):485-8. PubMed ID: 9859064
[TBL] [Abstract][Full Text] [Related]
3. [Effect of oral biphosphonates in patients with cystic fibrosis and low bone mineral density].
Ringuier B; Leboucher B; Leblanc M; Troussier F; Duveau E; Audran M; Giniès JL
Arch Pediatr; 2004 Dec; 11(12):1445-9. PubMed ID: 15596332
[TBL] [Abstract][Full Text] [Related]
4. Relation of bone mineral density with clinical and laboratory parameters in pre-pubertal children with cystic fibrosis.
Cobanoglu N; Atasoy H; Ozcelik U; Yalcin E; Dogru D; Kiper N; Gocmen A
Pediatr Pulmonol; 2009 Jul; 44(7):706-12. PubMed ID: 19504563
[TBL] [Abstract][Full Text] [Related]
5. Severe bone demineralisation is associated with higher mortality in children with cystic fibrosis.
O'Reilly R; Fitzpatrick P; Leen G; Elnazir B; Greally P
Ir Med J; 2009 Feb; 102(2):47-9. PubMed ID: 19405318
[TBL] [Abstract][Full Text] [Related]
6. Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study.
Malik P; Gasser RW; Kemmler G; Moncayo R; Finkenstedt G; Kurz M; Fleischhacker WW
Alcohol Clin Exp Res; 2009 Feb; 33(2):375-81. PubMed ID: 19053976
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in bone mineral density in epilepsy.
Sheth RD; Binkley N; Hermann BP
Epilepsia; 2008 Jan; 49(1):125-31. PubMed ID: 17683508
[TBL] [Abstract][Full Text] [Related]
8. Is significant cystic fibrosis-related liver disease a risk factor in the development of bone mineralization abnormalities?
Alex G; Catto-Smith AG; Ditchfield M; Roseby R; Robinson PJ; Cameron FJ; Oliver MR
Pediatr Pulmonol; 2006 Apr; 41(4):338-44. PubMed ID: 16477657
[TBL] [Abstract][Full Text] [Related]
9. Pubertal development and its influences on bone mineral density in Australian children and adolescents with cystic fibrosis.
Buntain HM; Greer RM; Wong JC; Schluter PJ; Batch J; Lewindon P; Bell SC; Wainwright CE
J Paediatr Child Health; 2005 Jul; 41(7):317-22. PubMed ID: 16014134
[TBL] [Abstract][Full Text] [Related]
10. Low bone mineral density in young children with cystic fibrosis.
Sermet-Gaudelus I; Souberbielle JC; Ruiz JC; Vrielynck S; Heuillon B; Azhar I; Cazenave A; Lawson-Body E; Chedevergne F; Lenoir G
Am J Respir Crit Care Med; 2007 May; 175(9):951-7. PubMed ID: 17272788
[TBL] [Abstract][Full Text] [Related]
11. A cross-sectional study of bone mineral density in children and adolescents attending a Cystic Fibrosis Centre.
Conway SP; Oldroyd B; Brownlee KG; Wolfe SP; Truscott JG
J Cyst Fibros; 2008 Nov; 7(6):469-76. PubMed ID: 18573696
[TBL] [Abstract][Full Text] [Related]
12. Docosahexaenoic acid is associated with endosteal circumference in long bones in young males with cystic fibrosis.
Gronowitz E; Lorentzon M; Ohlsson C; Mellström D; Strandvik B
Br J Nutr; 2008 Jan; 99(1):160-7. PubMed ID: 17697399
[TBL] [Abstract][Full Text] [Related]
13. The impact of dysglycaemia on bone mineral accrual in young people with cystic fibrosis.
Rana M; Munns CF; Selvadurai H; Briody J; Craig ME
Clin Endocrinol (Oxf); 2013 Jan; 78(1):36-42. PubMed ID: 22757766
[TBL] [Abstract][Full Text] [Related]
14. Gender differences in the prevalence and severity of bone disease in thalassaemia.
Kyriakou A; Savva SC; Savvides I; Pangalou E; Ioannou YS; Christou S; Skordis N
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():116-22. PubMed ID: 19337164
[TBL] [Abstract][Full Text] [Related]
15. Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF).
Chapman I; Greville H; Ebeling PR; King SJ; Kotsimbos T; Nugent P; Player R; Topliss DJ; Warner J; Wilson JW
Clin Endocrinol (Oxf); 2009 Jun; 70(6):838-46. PubMed ID: 18823395
[TBL] [Abstract][Full Text] [Related]
16. Musculoskeletal manifestations and rheumatic symptoms in patients with cystic fibrosis (CF) no observations of CF-specific arthropathy.
Koch AK; Brömme S; Wollschläger B; Horneff G; Keyszer G
J Rheumatol; 2008 Sep; 35(9):1882-91. PubMed ID: 18688909
[TBL] [Abstract][Full Text] [Related]
17. [Genetic risk markers of low bone mineral density in cystic fibrosis children].
Norek A; Sands D; Sobczyńska-Tomaszewska A; Chmielewski D; Szamotulska K; Czerska K; Bal J
Med Wieku Rozwoj; 2010; 14(4):334-43. PubMed ID: 21462477
[TBL] [Abstract][Full Text] [Related]
18. Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis.
Buntain HM; Schluter PJ; Bell SC; Greer RM; Wong JC; Batch J; Lewindon P; Wainwright CE
Thorax; 2006 Feb; 61(2):146-54. PubMed ID: 16384878
[TBL] [Abstract][Full Text] [Related]
19. Associations of genetic lactase non-persistence and sex with bone loss in young adulthood.
Laaksonen MM; Impivaara O; Sievänen H; Viikari JS; Lehtimäki TJ; Lamberg-Allardt CJ; Kärkkäinen MU; Välimäki M; Heikkinen J; Kröger LM; Kröger HP; Jurvelin JS; Kähönen MA; Raitakari OT;
Bone; 2009 May; 44(5):1003-9. PubMed ID: 19168163
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and predictors of osteopenia and osteoporosis in adults with Type 1 diabetes.
Hamilton EJ; Rakic V; Davis WA; Chubb SA; Kamber N; Prince RL; Davis TM
Diabet Med; 2009 Jan; 26(1):45-52. PubMed ID: 19125760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
